Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
cyclosporine calcium signal-modulating cyclophilin ligand small molecule NA drugbank , DGIDB Eczema[MeSHID:D004485]
Graft-vs-Host Disease[MeSHID:D006086]
Rupture[MeSHID:D012421]
Keratoconjunctivitis
Vernal[MeSHID:D003233]
Eye[MeSHID:D005123]
Nephrotic Syndrome[MeSHID:D009404]
Connective Tissue Diseases[MeSHID:D003240]
Kidney[MeSHID:D007668]
Juvenile arthritis[MeSHID:D001171]
Senile Plaques[MeSHID:D058225]
Mental Suffering[MeSHID:D013315]
Immune thrombocytopenic purpura[MeSHID:D016553]
Psoriasis[MeSHID:D011565]
Keratoconjunctivitis Sicca[MeSHID:D007638]
Liver[MeSHID:D008099]
Rheumatoid Arthritis[MeSHID:D001172]
Segmental glomerulosclerosis[MeSHID:C538457]
Dental Plaque[MeSHID:D003773]
Membranous glomerulonephritis[MeSHID:D015433]
Bulla[MeSHID:D001768]
Tears body substance[MeSHID:D013666]
Lipoid nephrosis[MeSHID:D009402]
Ulcerative Colitis[MeSHID:D003093]
Immunocompromised Host[MeSHID:D016867]
Disease[MeSHID:D004194]
Graft Rejection[MeSHID:D006084]
Dry Eye Syndromes[MeSHID:D015352]
Kidney Glomerulus[MeSHID:D007678]
Dermatitis
Atopic[MeSHID:D003876]
Laceration[MeSHID:D022125]
Uveitis[MeSHID:D014605]		 9.24 approved,investigational,vet_approved binder
cyclosporine peptidyl-prolyl cis-trans isomerase a small molecule NA drugbank , DGIDB Eczema[MeSHID:D004485]
Graft-vs-Host Disease[MeSHID:D006086]
Rupture[MeSHID:D012421]
Keratoconjunctivitis
Vernal[MeSHID:D003233]
Eye[MeSHID:D005123]
Nephrotic Syndrome[MeSHID:D009404]
Connective Tissue Diseases[MeSHID:D003240]
Kidney[MeSHID:D007668]
Juvenile arthritis[MeSHID:D001171]
Senile Plaques[MeSHID:D058225]
Mental Suffering[MeSHID:D013315]
Immune thrombocytopenic purpura[MeSHID:D016553]
Psoriasis[MeSHID:D011565]
Keratoconjunctivitis Sicca[MeSHID:D007638]
Liver[MeSHID:D008099]
Rheumatoid Arthritis[MeSHID:D001172]
Segmental glomerulosclerosis[MeSHID:C538457]
Dental Plaque[MeSHID:D003773]
Membranous glomerulonephritis[MeSHID:D015433]
Bulla[MeSHID:D001768]
Tears body substance[MeSHID:D013666]
Lipoid nephrosis[MeSHID:D009402]
Ulcerative Colitis[MeSHID:D003093]
Immunocompromised Host[MeSHID:D016867]
Disease[MeSHID:D004194]
Graft Rejection[MeSHID:D006084]
Dry Eye Syndromes[MeSHID:D015352]
Kidney Glomerulus[MeSHID:D007678]
Dermatitis
Atopic[MeSHID:D003876]
Laceration[MeSHID:D022125]
Uveitis[MeSHID:D014605]		 2.82 approved,investigational,vet_approved inhibitor,binder,modulator
cyclosporine peptidyl-prolyl cis-trans isomerase a small molecule NA drugbank , DGIDB Eczema[MeSHID:D004485]
Graft-vs-Host Disease[MeSHID:D006086]
Rupture[MeSHID:D012421]
Keratoconjunctivitis
Vernal[MeSHID:D003233]
Eye[MeSHID:D005123]
Nephrotic Syndrome[MeSHID:D009404]
Connective Tissue Diseases[MeSHID:D003240]
Kidney[MeSHID:D007668]
Juvenile arthritis[MeSHID:D001171]
Senile Plaques[MeSHID:D058225]
Mental Suffering[MeSHID:D013315]
Immune thrombocytopenic purpura[MeSHID:D016553]
Psoriasis[MeSHID:D011565]
Keratoconjunctivitis Sicca[MeSHID:D007638]
Liver[MeSHID:D008099]
Rheumatoid Arthritis[MeSHID:D001172]
Segmental glomerulosclerosis[MeSHID:C538457]
Dental Plaque[MeSHID:D003773]
Membranous glomerulonephritis[MeSHID:D015433]
Bulla[MeSHID:D001768]
Tears body substance[MeSHID:D013666]
Lipoid nephrosis[MeSHID:D009402]
Ulcerative Colitis[MeSHID:D003093]
Immunocompromised Host[MeSHID:D016867]
Disease[MeSHID:D004194]
Graft Rejection[MeSHID:D006084]
Dry Eye Syndromes[MeSHID:D015352]
Kidney Glomerulus[MeSHID:D007678]
Dermatitis
Atopic[MeSHID:D003876]
Laceration[MeSHID:D022125]
Uveitis[MeSHID:D014605]		 2.82 approved,investigational,vet_approved inhibitor,binder
cyclosporine peptidyl-prolyl cis-trans isomerase f, mitochondrial small molecule NA drugbank Eczema[MeSHID:D004485]
Graft-vs-Host Disease[MeSHID:D006086]
Rupture[MeSHID:D012421]
Keratoconjunctivitis
Vernal[MeSHID:D003233]
Eye[MeSHID:D005123]
Nephrotic Syndrome[MeSHID:D009404]
Connective Tissue Diseases[MeSHID:D003240]
Kidney[MeSHID:D007668]
Juvenile arthritis[MeSHID:D001171]
Senile Plaques[MeSHID:D058225]
Mental Suffering[MeSHID:D013315]
Immune thrombocytopenic purpura[MeSHID:D016553]
Psoriasis[MeSHID:D011565]
Keratoconjunctivitis Sicca[MeSHID:D007638]
Liver[MeSHID:D008099]
Rheumatoid Arthritis[MeSHID:D001172]
Segmental glomerulosclerosis[MeSHID:C538457]
Dental Plaque[MeSHID:D003773]
Membranous glomerulonephritis[MeSHID:D015433]
Bulla[MeSHID:D001768]
Tears body substance[MeSHID:D013666]
Lipoid nephrosis[MeSHID:D009402]
Ulcerative Colitis[MeSHID:D003093]
Immunocompromised Host[MeSHID:D016867]
Disease[MeSHID:D004194]
Graft Rejection[MeSHID:D006084]
Dry Eye Syndromes[MeSHID:D015352]
Kidney Glomerulus[MeSHID:D007678]
Dermatitis
Atopic[MeSHID:D003876]
Laceration[MeSHID:D022125]
Uveitis[MeSHID:D014605]		 NA approved,investigational,vet_approved binder
cyclosporine calcineurin subunit b type 2 small molecule NA drugbank , DGIDB Eczema[MeSHID:D004485]
Graft-vs-Host Disease[MeSHID:D006086]
Rupture[MeSHID:D012421]
Keratoconjunctivitis
Vernal[MeSHID:D003233]
Eye[MeSHID:D005123]
Nephrotic Syndrome[MeSHID:D009404]
Connective Tissue Diseases[MeSHID:D003240]
Kidney[MeSHID:D007668]
Juvenile arthritis[MeSHID:D001171]
Senile Plaques[MeSHID:D058225]
Mental Suffering[MeSHID:D013315]
Immune thrombocytopenic purpura[MeSHID:D016553]
Psoriasis[MeSHID:D011565]
Keratoconjunctivitis Sicca[MeSHID:D007638]
Liver[MeSHID:D008099]
Rheumatoid Arthritis[MeSHID:D001172]
Segmental glomerulosclerosis[MeSHID:C538457]
Dental Plaque[MeSHID:D003773]
Membranous glomerulonephritis[MeSHID:D015433]
Bulla[MeSHID:D001768]
Tears body substance[MeSHID:D013666]
Lipoid nephrosis[MeSHID:D009402]
Ulcerative Colitis[MeSHID:D003093]
Immunocompromised Host[MeSHID:D016867]
Disease[MeSHID:D004194]
Graft Rejection[MeSHID:D006084]
Dry Eye Syndromes[MeSHID:D015352]
Kidney Glomerulus[MeSHID:D007678]
Dermatitis
Atopic[MeSHID:D003876]
Laceration[MeSHID:D022125]
Uveitis[MeSHID:D014605]		 7.19 approved,investigational,vet_approved inhibitor
click here to return to the previous page